329 related articles for article (PubMed ID: 14739095)
1. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.
Shawcross DL; Davies NA; Williams R; Jalan R
J Hepatol; 2004 Feb; 40(2):247-54. PubMed ID: 14739095
[TBL] [Abstract][Full Text] [Related]
2. Role of ammonia and inflammation in minimal hepatic encephalopathy.
Shawcross DL; Wright G; Olde Damink SW; Jalan R
Metab Brain Dis; 2007 Mar; 22(1):125-38. PubMed ID: 17260161
[TBL] [Abstract][Full Text] [Related]
3. Low myo-inositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia.
Shawcross DL; Balata S; Olde Damink SW; Hayes PC; Wardlaw J; Marshall I; Deutz NE; Williams R; Jalan R
Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G503-9. PubMed ID: 15130875
[TBL] [Abstract][Full Text] [Related]
4. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy.
Rodrigo R; Cauli O; Gomez-Pinedo U; Agusti A; Hernandez-Rabaza V; Garcia-Verdugo JM; Felipo V
Gastroenterology; 2010 Aug; 139(2):675-84. PubMed ID: 20303348
[TBL] [Abstract][Full Text] [Related]
5. Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy.
Felipo V; Urios A; Montesinos E; Molina I; Garcia-Torres ML; Civera M; Olmo JA; Ortega J; Martinez-Valls J; Serra MA; Cassinello N; Wassel A; Jordá E; Montoliu C
Metab Brain Dis; 2012 Mar; 27(1):51-8. PubMed ID: 22072427
[TBL] [Abstract][Full Text] [Related]
6. Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis.
Balata S; Olde Damink SW; Ferguson K; Marshall I; Hayes PC; Deutz NE; Williams R; Wardlaw J; Jalan R
Hepatology; 2003 Apr; 37(4):931-9. PubMed ID: 12668989
[TBL] [Abstract][Full Text] [Related]
7. Oral amino acid load mimicking hemoglobin results in reduced regional cerebral perfusion and deterioration in memory tests in patients with cirrhosis of the liver.
Jalan R; Olde Damink SW; Lui HF; Glabus M; Deutz NE; Hayes PC; Ebmeier K
Metab Brain Dis; 2003 Mar; 18(1):37-49. PubMed ID: 12603081
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.
Merli M; Lucidi C; Pentassuglio I; Giannelli V; Giusto M; Di Gregorio V; Pasquale C; Nardelli S; Lattanzi B; Venditti M; Riggio O
J Hepatol; 2013 Aug; 59(2):243-50. PubMed ID: 23523580
[TBL] [Abstract][Full Text] [Related]
9. Is hyperammonemia really the true cause of altered neuropsychology, brain MR spectroscopy and magnetization transfer after an oral amino acid load in cirrhosis?
Riggio O; Efrati C; Masini A; Angeloni S; Merli M
Hepatology; 2003 Sep; 38(3):777; author reply 778. PubMed ID: 12939607
[No Abstract] [Full Text] [Related]
10. Inflammation and hepatic encephalopathy.
Coltart I; Tranah TH; Shawcross DL
Arch Biochem Biophys; 2013 Aug; 536(2):189-96. PubMed ID: 23583306
[TBL] [Abstract][Full Text] [Related]
11. Induced hyperammonemia may compromise the ability to generate restful sleep in patients with cirrhosis.
Bersagliere A; Raduazzo ID; Nardi M; Schiff S; Gatta A; Amodio P; Achermann P; Montagnese S
Hepatology; 2012 Mar; 55(3):869-78. PubMed ID: 21994139
[TBL] [Abstract][Full Text] [Related]
12. Factors contributing to the development of overt encephalopathy in liver cirrhosis patients.
Iwasa M; Sugimoto R; Mifuji-Moroka R; Hara N; Yoshikawa K; Tanaka H; Eguchi A; Yamamoto N; Sugimoto K; Kobayashi Y; Hasegawa H; Takei Y
Metab Brain Dis; 2016 Oct; 31(5):1151-6. PubMed ID: 27353278
[TBL] [Abstract][Full Text] [Related]
13. Pro-inflammatory cytokines are raised in extrahepatic portal venous obstruction, with minimal hepatic encephalopathy.
Srivastava A; Yadav SK; Yachha SK; Thomas MA; Saraswat VA; Gupta RK
J Gastroenterol Hepatol; 2011 Jun; 26(6):979-86. PubMed ID: 21362045
[TBL] [Abstract][Full Text] [Related]
14. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.
Jain L; Sharma BC; Sharma P; Srivastava S; Agrawal A; Sarin SK
Dig Liver Dis; 2012 Dec; 44(12):1027-31. PubMed ID: 22883217
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of Helicobacter pylori in liver cirrhosis complicated with hepatic encephalopathy].
Săndulache L; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1056-60. PubMed ID: 20191873
[TBL] [Abstract][Full Text] [Related]
17. Ammonia levels and the severity of hepatic encephalopathy.
Qureshi MO; Khokhar N; Shafqat F
J Coll Physicians Surg Pak; 2014 Mar; 24(3):160-3. PubMed ID: 24613109
[TBL] [Abstract][Full Text] [Related]
18. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.
Shawcross DL; Sharifi Y; Canavan JB; Yeoman AD; Abeles RD; Taylor NJ; Auzinger G; Bernal W; Wendon JA
J Hepatol; 2011 Apr; 54(4):640-9. PubMed ID: 21163546
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Encephalopathy Aggravated by Systemic Inflammation.
Manzhalii E; Virchenko O; Falalyeyeva T; Moiseienko V; Nykula T; Kondratiuk V; Savchuk O; Beregova T; Stremmel W
Dig Dis; 2019; 37(6):509-517. PubMed ID: 31170723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
